International Journal of Drug Policy

Papers
(The median citation count of International Journal of Drug Policy is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Tackling the overdose crisis: The role of safe supply113
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets110
An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples109
Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study87
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”78
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada76
Safer opioid distribution in response to the COVID-19 pandemic73
COVID-19 and the health of people who use drugs: What is and what could be?68
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update67
Syringe services program (SSP) operational changes during the COVID-19 global outbreak67
An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods64
Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?63
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System61
Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky59
The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England56
Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern56
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-1955
“You are not clean until you're not on anything”: Perceptions of medication-assisted treatment in rural Appalachia54
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences49
Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets49
Access to cannabidiol without a prescription: A cross-country comparison and analysis47
COVID-19 - Enacting a ‘new normal’ for people who use drugs44
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-1943
Care during COVID-19: Drug use, harm reduction, and intimacy during a global pandemic43
Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States43
From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic42
Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use41
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 201941
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis41
Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs41
Doing ontopolitically-oriented research: Synthesising concepts from the ontological turn for alcohol and other drug research and other social sciences41
Drugs as technologies of the self: Enhancement and transformation in LGBTQ cultures40
Known fentanyl use among clients of harm reduction sites in British Columbia, Canada40
A narrative systematic review of sexualised drug use and sexual health outcomes among LGBT people38
Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market37
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-1937
“How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic36
Intentions, actions and outcomes: A follow up survey on harm reduction practices after using an English festival drug checking service36
Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs36
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework36
Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley35
Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain34
Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs33
Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies32
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study32
Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: An ethnographic study32
Overdose among mothers: The association between child removal and unintentional drug overdose in a longitudinal cohort of marginalised women in Canada32
The protective effect of trusted dealers against opioid overdose in the U.S.31
Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone31
The impact of cannabis legalization in Uruguay on adolescent cannabis use30
“Bed Bugs and Beyond”: An ethnographic analysis of North America's first women-only supervised drug consumption site30
Prevalence, frequency, and motivations for alkyl nitrite use among gay, bisexual and other men who have sex with men in Australia30
HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C29
“I couldn't live with killing one of my friends or anybody”: A rapid ethnographic study of drug sellers’ use of drug checking29
Race, cannabis and the Canadian war on drugs: An examination of cannabis arrest data by race in five cities29
Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada29
Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey29
Injecting drug use during sex (known as “slamming”) among men who have sex with men: Results from a time-location sampling survey conducted in five cities, France29
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada29
International differences in patterns of cannabis use among adult cigarette smokers: Findings from the 2018 ITC Four Country Smoking and Vaping Survey28
Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic28
Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects28
Trajectories of retention in opioid agonist therapy in a Canadian setting28
Rural risk environments, opioid-related overdose, and infectious diseases: A multidimensional, spatial perspective28
Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis28
Police-related barriers to harm reduction linked to non-fatal overdose amongst sex workers who use drugs: Results of a community-based cohort in Metro Vancouver, Canada27
The perfect storm: COVID-19, mass incarceration and the opioid epidemic27
‘Peer’ work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work27
Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use27
Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland27
The Bell Tolls for Thee & Thine: Compassion Fatigue & the Overdose Epidemic27
Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors27
“It's like super structural” – Overdose experiences of youth who use drugs and police in three non-metropolitan cities across British Columbia27
Price and product variation in Washington's recreational cannabis market26
Is South Africa being spared the global opioid crisis? A review of trends in drug treatment demand for heroin, nyaope and codeine-related medicines in South Africa (2012–2017)26
An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom26
Framing and scientific uncertainty in nicotine vaping product regulation: An examination of competing narratives among health and medical organisations in the UK, Australia and New Zealand26
“It's an emotional roller coaster… But sometimes it's fucking awesome”: Meaning and motivation of work for peers in overdose response environments in British Columbia26
We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers26
No “back to normal” after COVID-19 for our failed drug policies26
Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives25
‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram25
“I probably got a minute”: Perceptions of fentanyl test strip use among people who use stimulants25
Divergences and commonalities between the US opioid crisis and prescription medicine mis/use in West Africa25
Stigma, discrimination and crystal methamphetamine (‘ice’): Current attitudes in Australia25
Re-configured pleasures: How young people feel good through abstaining or moderating their drinking25
Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market25
Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast24
People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky24
One “chemsex” or many? Types of chemsex sessions among gay and other men who have sex with men in Madrid, Spain: findings from a qualitative study24
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minima23
“Doing What Is Right and Doing It Right”: A Mapping Review of Athletes' Perception of Anti-Doping Legitimacy23
Fentanyl panic goes viral: The spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media23
Preliminary findings of the impact of COVID-19 on drugs crypto markets23
Portable gas chromatography–mass spectrometry in drug checking: Detection of carfentanil and etizolam in expected opioid samples23
MDMA-related deaths in Australia 2000 to 201823
Alcohol consumption and attributable harm in middle-income South-East Asian countries: Epidemiology and policy options22
The internet market for Kratom, an opioid alternative and variably legal recreational drug22
Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services22
Drugs and drug wars as populist tropes in Asia: Illustrative examples and implications for drug policy22
Digital chemsex support and care: The potential of just-in-time adaptive interventions22
No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions22
Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington22
The impact of rurality on opioid-related harms: A systematic review of qualitative research22
Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets22
Alcohol policy has saved lives in the Russian Federation21
Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs21
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply21
Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research21
The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs21
Producing the vulnerable subject in English drug policy21
Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting21
Enacting ‘more-than-human’ care: Clients’ and counsellors’ views on the multiple affordances of chatbots in alcohol and other drug counselling21
Peer-delivered services for substance use in low- and middle-income countries: A systematic review21
Message framing to reduce stigma and increase support for policies to improve the wellbeing of people with prior drug convictions20
Latent patterns of polysubstance use among people who use opioids: A systematic review20
The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review20
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures20
Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-1920
Frequency of injecting among people who inject drugs: A systematic review and meta-analysis20
Good Samaritan laws and overdose mortality in the United States in the fentanyl era20
“Everybody living with a chronic disease is entitled to be cured”: Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drug20
Legal cannabis market shares during Canada's first year of recreational legalisation20
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence20
Factors associated with methamphetamine dependency among men who have sex with men engaging in chemsex: Findings from the COMeT study in Taiwan19
The pharmaceuticalisation of ‘healthy’ ageing: Testosterone enhancement for longevity19
Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers19
“Towards eliminating viral hepatitis”: Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination19
Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations19
Between gang talk and prohibition: The transfer of blame for County Lines19
Uncertainty and risk: A framework for understanding pricing in online drug markets19
Tough Tradeoffs: Coca crops and agrarian alternatives in Colombia19
Alcohol and drinking within the lives of midlife women: A meta-study systematic review19
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence19
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs19
Critical studies of harm reduction: Overdose response in uncertain political times19
The effectiveness of drug-related Good Samaritan laws: A review of the literature19
Trends in cannabis use among U.S. adults amid the COVID-19 pandemic18
More-than-harm reduction: Engaging with alternative ontologies of ‘movement’ in UK drug services18
Producing the ‘problem’ of new psychoactive substances (NPS) in English prisons18
‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States18
A systematic review of cigarette smoking trajectories in adolescents18
Individual and network factors associated with HCV treatment uptake among people who inject drugs18
Consumer protection in drug policy: The human rights case for safe supply as an element of harm reduction18
Intensity of cannabis use: Findings from three online surveys18
Legitimizing and negotiating abstinence: Young adults’ narratives about practicing situational and long term abstinence in Denmark.18
Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin18
“Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs17
Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic–Is an update of legal restrictions warranted?17
Help me fix: The provision of injection assistance at an unsanctioned overdose prevention site in Toronto, Canada17
The effects of the iPlayClean education programme on doping attitudes and susceptibility to use banned substances among high-level adolescent athletes from the UK: A cluster-randomised controlled tria17
Simple possession as a ‘tool’: Drug law enforcement practices among police officers in the context of depenalization in British Columbia, Canada17
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months17
‘It’s good being part of the community and doing the right thing’: (Re)problematising ‘community’ in new recovery-oriented policy and consumer accounts17
Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia17
“You don’t have to squirrel away in a staircase”: Patient motivations for attending a novel supervised drug consumption service in acute care17
A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment17
Refusal to accept emergency medical transport following opioid overdose, and conditions that may promote connections to care17
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada17
Extended lockdown and India’s alcohol policy: a qualitative analysis of newspaper articles17
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis17
Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets17
The Pat Jasan drug eradication social movement in Northern Myanmar, part one: Origins & reactions16
Stigma as understood by key informants: A social ecological approach to gay and bisexual men's use of crystal methamphetamine for sex16
Growing pains: An overview of cannabis quality control and quality assurance in Canada16
Effects of strengthening alcohol labels on attention, message processing, and perceived effectiveness: A quasi-experimental study in Yukon, Canada16
A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada16
‘What makes up wine o'clock? Understanding social practices involved in alcohol use among women aged 40–65 years in Australia16
Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE)16
Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks16
‘I feel like I have to become part of that identity’: Negotiating femininities and friendships through alcohol consumption in Newcastle, UK16
Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Aust16
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy16
Unity in diversity: A systematic review on the GHB using population16
Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina16
Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics16
Carfentanil on the darknet: Potential scam or alarming public health threat?16
A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage16
Testing the boundaries: Self-medicated testosterone replacement and why it is practised16
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England16
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing16
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids16
Sources of cannabis among young adults and associations with cannabis-related outcomes16
Investigating opioid preference to inform safe supply services: A cross sectional study16
Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: A systematic review and practical considerations from an expert panel consultation15
Pharmacosex: Reimagining sex, drugs and enhancement15
Rethinking enhancement substance use: A critical discourse studies approach15
Beyond a ‘post-cure’ world: Sketches for a new futurology of hepatitis C15
Possibilities and pitfalls? Moderate drinking and alcohol abstinence at home since the COVID-19 lockdown15
Trends in opioid-related crime incidents and comparison with opioid overdose outcomes in the United States15
Public support for alcohol control initiatives across seven countries15
Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study15
Connections built and broken: The ontologies of relapse15
Precarity, poverty and poppy: Encountering development in the uplands of Shan State, Myanmar15
How to think with models and targets: Hepatitis C elimination as a numbering performance15
Association of alcohol control policies with adolescent alcohol consumption and with social inequality in adolescent alcohol consumption: A multilevel study in 33 countries and regions15
Effects of messaging on public support for drug consumption rooms in scotland, UK15
A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island15
Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex15
Effectiveness of a school-based substance use prevention program taught by police officers in Brazil: Two cluster randomized controlled trials of the PROERD15
A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic15
Exploring the role of trauma in underpinning sexualised drug use (‘chemsex’) among gay, bisexual and other men who have sex with men in Singapore15
The substitution program on trial: progress and setbacks of the peace agreement in the policy against illicit crops in Colombia15
Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data15
Can google trends search inform us about the population response and public health impact of abrupt change in alcohol policy? A case study from India during the covid-19 pandemic15
The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada15
What explains the decline in adolescent binge-drinking in New Zealand?15
Youth drinking in decline: What are the implications for public health, public policy and public debate?15
Alarming increase in poisonings from recreational nitrous oxide use after a change in EU-legislation, inquiries to the Dutch Poisons Information Center15
A qualitative study of a publicly funded pharmacy-dispensed naloxone program15
Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting15
The success rate of online illicit drug transactions during a global pandemic14
Operational and contextual barriers to accessing supervised consumption services in two Canadian cities14
Examining the implementation of police-assisted referral programs for substance use disorder services in Massachusetts14
“You can't go wrong being safe”: Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs14
Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis14
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot14
A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia14
Perceived vulnerability to overdose-related arrests among people who use drugs in Maryland14
Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway14
Medicinal cannabis and driving: the intersection of health and road safety policy14
Drug induced homicide laws may worsen opioid related harms: An example from rural North Carolina14
Analytical findings in used syringes from a syringe exchange program14
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-14
Isolating the isolated: Implications of COVID-19 quarantine measures on in-patient detoxification treatment for substance use disorders14
Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis14
Opioids, stimulants, and depressant drugs in fifteen Mexican Cities: A wastewater-based epidemiological study14
A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons14
‘Social health’, ‘physical health’, and well-being: Analysing with bourdieusian concepts the interplay between the practices of heavy drinking and exercise among young people14
Co-creating a social science research agenda for clean sport: An international Delphi study14
The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation14
What is the face of new nicotine users? 2012–2018 e-cigarettes and tobacco use among young students in Italy14
Poppers, queer sex and a Canadian crackdown: Examining the experiences of alkyl nitrite use among young sexual minority men14
How medical are states’ medical cannabis policies?: Proposing a standardized scale14
The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use14
#studydrugs–Persuasive posting on Instagram13
Beyond the narco frontier; rethinking an imaginary of the margins13
Predictors of work engagement among Australian non-government drug and alcohol employees: Implications for policy and practice13
Hospital policy as a harm reduction intervention for people who use drugs13
Recreational drug use and use of drugs associated with chemsex among HIV-negative and HIV-positive heterosexual men and women attending sexual health and HIV clinics in England13
Risk and enabling environments in sport: Systematic doping as harm reduction13
The effect of injecting alone on the use of drug checking services among people who inject drugs13
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort13
Attitudes towards Kratom use, decriminalization and the development of a community-based Kratom control mechanism in Southern Thailand13
The impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within the homeless population: Markets, content and user harms13
Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors13
Critical realism and the ‘ontological politics of drug policy’13
Perceived Importance of Factors in Cannabis Purchase Decisions: A Best-worst Scaling Experiment13
Young women’s narratives on sex in the context of heavy alcohol use: Friendships, gender norms and the sociality of consent13
A normalised future of addiction12
0.019844055175781